Abstract: Biologically active extract of Hibiscus tiliaceus L. and compositions comprising the extract are described. The invention also provides therapeutic uses of the extract and compositions, in particular for promoting healing of bone and cartilage injuries, and the promotion of bone and cartilage formation.
Abstract: A composition comprising an extract from an aquatic organism is disclosed. The composition is capable of preventing adhesion of a cell to a surface and is devoid of cytotoxic or cytostatic activity. Medical devices comprising same and methods for preventing or treating a pathological infection using same are also disclosed.
Type:
Grant
Filed:
September 21, 2008
Date of Patent:
August 22, 2017
Assignee:
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Inventors:
Amir Zlotkin, Eliahu Zlotkin, Amir Zlotkin
Abstract: An extract of the marine algae, Sarcodiotheca, and more particularly Sarcodiotheca gaudichaudii, is described for use in cosmetic compositions. A biofermentation of Sarcodiotheca, such as for example S. gaudichaudii, is also described. This marine bioferment is useful as a skin care active ingredient for anti-aging cosmetic applications, and particularly useful when used in combination with an extracts of red algae, such as Chondrus crispus.
Type:
Grant
Filed:
May 16, 2012
Date of Patent:
August 1, 2017
Assignee:
BASF Corporation
Inventors:
Joseph D. Ceccoli, Brian Costello, Sreekumar Pillai
Abstract: A composition containing cinnamon extract reduces and/or eliminates one or more risk factors associated with Syndrome X. The composition also includes optionally one of more components selected from the group consisting of vitamins, cholesterol lowering agents, lipid lowering agents, and glucose lowering agent. Also described is a method of reducing and/or eliminating risk factors associated with Syndrome X in a subject through the administration of the cinnamon extract. The cinnamon extract supplement is administered orally, intravenously, or subcutaneously. In one embodiment, a daily dose of 10-1,000 mg of the cinnamon extract supplement is administered to the subject for a period of 6 weeks to 6 months.
Abstract: The present invention relates to a formulation comprising whey protein or a hydrolysate of whey protein, which formulation is capable of inhibiting the expression of TNF? in lipopolysaccharide-stimulated macrophages in vitro. Also provided are uses of the formulation for attenuating a reduction in muscle function which results from muscle damage and/or for enhancing recovery from muscle damage and/or for enhancing the force generating capacity of muscle and methods of making the formulation.
Type:
Grant
Filed:
June 15, 2007
Date of Patent:
May 30, 2017
Assignee:
MURRAY GOULBURN CO-OPERATIVE., LIMITED
Inventors:
Michelle Rowney, Andrew Brown, Yu Pan, Jonathan David Buckley
Abstract: Biologically active extracts of one or more Vigna marina (Burm.) Merr., Cocos nucifera L., or Terminalia catappa L. and compositions one or more of the extracts are described. The invention also provides therapeutic and cosmetic uses of the extracts and compositions, in particular for promoting wound healing and for the treatment of skin disorders.
Abstract: Disclosed is a topical skin composition comprising an aqueous extract from a part of Nymphaea gigantea, wherein said part consists of the flower of Nymphaea gigantea, an aqueous extract from a part of Plumeria alba, wherein said part consists of the flower of Plumeria alba, and a dermatologically acceptable vehicle.
Type:
Grant
Filed:
May 24, 2013
Date of Patent:
April 25, 2017
Assignee:
Mary Kay Inc.
Inventors:
Tiffany Florence, David Gan, Michelle Hines
Abstract: Disclosed herein are compounds, extracts, and active fractions of the plant Geum japonicum and methods for increasing longevity and survival potency or for preventing or treating various medical conditions, including diabetes, inflammation, wound healing, bed sores, and ocular disorders. The compounds provided herein can be formulated into pharmaceutical compositions and medicaments that are useful in the disclosed methods. Also provided are the use of the compounds and extracts in preparing pharmaceutical formulations and medicaments.
Abstract: The present disclosure discloses a method for treating vascular inflammation, improving skin beauty and improving male sexual function of a subject by administering a ginseng berry extract to the subject.
Type:
Grant
Filed:
May 9, 2014
Date of Patent:
March 21, 2017
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Chan-Woong Park, Myeong Hoon Yeom, Nam Hoon Cho, Sang Jun Lee, Sang Min Lee, Jin Young Lee, Hee Yong Jeon, Young-Myeong Kim, Chun-Ki Kim, Young Deuk Choi
Abstract: A fractionation process for producing value-added products from a lignocellulosic biomass, comprises: a) mechanically refining the lignocellulosic biomass under mild refining conditions to form a refined biomass pulp with enhanced susceptibility to separation of hemicellulose, cellulose and lignin, and enhanced digestibility of carbohydrates in hydrolysis b) separating hemicellulose and sulfur-free high-quality lignin from cellulose in the refined biomass, and, optionally c) producing various bioproducts from the above said process.
Type:
Grant
Filed:
November 10, 2010
Date of Patent:
February 28, 2017
Assignee:
FPINNOVATIONS
Inventors:
Zhirun Yuan, Thomas Carl Browne, Xiao Zhang
Abstract: Methods for recovering valuable compounds and substances from plants after distillation of oils are disclosed. The methods involve various aqueous and non-aqueous solvent extraction of plant material from which oils have been distilled previously.
Abstract: The invention relates to a preparation containing several amino acids and plant extracts and its alcohol detoxification activity. The component (a) in the preparation contains a mixture of two or more amino acids or derivatives thereof; the component (b) in the preparation contains a mixture of three or more extracts from plants. There are several plant extracts used in this invention such as the extract of ginseng radix, the extract of ginkgo biloba leaf, the extract of Silibinin, the extract of barbury wolfberry fruit and tea polyphenols. The invention also relates to the biological activities of said preparation, such as the liver protection from chemical injury, the tolerance enhancement of hypoxy and the rapid decrease till elimination of the blood alcohol content.
Type:
Grant
Filed:
October 28, 2010
Date of Patent:
December 27, 2016
Assignees:
MODUTECH S.A., HANGZHOU ADAMERCK PHARMSLABS INC.
Abstract: Disclosed is a composition, and method for its use, that includes any one of, any combination of, or all of Centella asiactica, Vitis vinifera seed, Magnolia bark, Camellia sinensis, and/or dihydroxymethylchromone. The composition can be used to treat telangiectasia.
Abstract: This invention generally provides depigmenting cosmetic compositions comprising four active whitening ingredients: undecylenoyl phenylalanine, alpha-arbutin, kojic acid and brassica napus extract, and methods for forming the same.
Abstract: A method for preparing a processed ginseng or a processed ginseng extract having increased contents of ginsenosides Rg3 and Rh2 by (a) inoculating an Aspergillus niger strain into a medium composed of ginseng and wheat bran; (b) culturing the strain of step (a); (c) purifying the cultured material of step (b) by ultrafiltration; (d) separating an enzyme from the purified material of step (c); (e) adding the enzyme of step (d) to ginseng or red ginseng; (f) fermenting the ginseng or red ginseng of step (e); (g) separating the fermented material of step (f) to obtain a supernatant; (h) concentrating the supernatant of step (g); (i) reacting the concentrate of step (h) with organic acid; and (j) neutralizing, filtering, purifying, concentrating and drying the reaction product of step (i).
Type:
Grant
Filed:
May 13, 2011
Date of Patent:
December 6, 2016
Assignee:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Young-Hyo Yoo, Sun-Ok Kim, Jung Hyo Choi, Soo-Hyun Bae, Sun Kyu Park, Jeom Yong Kim
Abstract: Process for removing pesticides from Ginkgo biloba extracts, which involves submitting an extract obtained by conventional methods to the following steps: a. Liquid-liquid extraction of the extract to obtain a medium polarity fraction containing ginkgo terpenes and pesticides not removable with hexane, and a high polarity fraction containing ginkgo flavone glycosides; b. crystallization from the medium polarity fraction obtained at step a) to give an intermediate with a ginkgolide content of not less than 50%; c. crystallization from the residual solution obtained at step b) to give an intermediate with a bilobalide content of not less than 50%; d. mixing of the high polarity fraction obtained at step a) with the ginkgo terpene intermediate and the bilobalide intermediate obtained at steps b) and c).
Type:
Grant
Filed:
March 31, 2010
Date of Patent:
November 29, 2016
Assignee:
INDENA S.P.A.
Inventors:
Andrea Giori, Giacomo Mombelli, Sabrina Arpini, Mario Acerbi
Abstract: The present invention discloses the extracts of Holoptelea integrifolia or the purified fractions isolated there from and the dietary, nutraceutical and pharmaceutical compositions comprising the same or optionally in combination with one or more known anti-obesic agents useful for the purpose of inhibition, amelioration or prevention of adipogenesis and lipolysis involved diseases. The invention further discloses a method for treating or preventing obesity and adipogenesis and lipolysis involved diseases using the compositions containing the extracts of purified fractions of Holoptelea integrifolia.
Abstract: The present invention relates to the obesity-curative or obesity-preventive effect of a Polygonum cuspidatum butanol fraction and a Polygonum cuspidatum ethylacetate fraction, and more particularly, to a pharmaceutical composition and a functional food for treating obesity, the pharmaceutical composition and the functional food comprising a Polygonum cuspidatum butanol fraction (POCU-1b) and an ethylacetate fraction as active ingredients, wherein the Polygonum cuspidatum butanol fraction and the ethylacetate fraction inhibit effectively the activity of pancreatic lipase, an important enzyme involving in fat absorption in a living body, and have excellent inhibitory effect on fat absorption in the short term fat absorption-inhibitory animal experiments using lipid emulsions.
Type:
Grant
Filed:
December 29, 2009
Date of Patent:
November 29, 2016
Assignee:
KOREA INSTITUTE OF ORIENTAL MEDICINE
Inventors:
Jin Sook Kim, Dae Sik Jang, Young Sook Kim, Junghyun Kim, Chan-Sik Kim
Abstract: The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation.
Abstract: A composition for use in inhibiting or killing Porphyromonas gingivalis, comprising an effective amount of Antrodia camphorata powder or extract and acceptable carriers thereof for inhibiting or killing Porphyromonas gingivalis. Also provided is a method of inhibiting or killing Porphyromonas gingivalis by using aforementioned composition. Further provided is a method of alleviating or treating diseases derived from Porphyromonas gingivalis by administrating a therapeutically effective amount of aforementioned composition. The Antrodia camphorata extract in accordance with the present invention have been proved having the efficacy of inhibiting or killing Porphyromonas gingivalis, and thus can be easily applied to various fields, particularly, health foods, drinks and applications of daily supplies. Moreover, advantages in accordance with the present invention include no side effects, easy fabricating and low cost.
Type:
Grant
Filed:
March 5, 2012
Date of Patent:
November 1, 2016
Assignee:
Yushen Biotechnology & Medical Co., Ltd.